Company intelligence / Profile preview

GeneFirst

Abingdon, Oxfordshire, United Kingdomgenefirst.com ↗

Ownership: Private
Development stage: Other

Overview

GeneFirst develops and commercializes proprietary molecular diagnostic technologies for oncology (cancer), women’s health/cervical cancer screening via HPV testing, and infectious disease detection. Its platforms enable highly sensitive detection of mutations or pathogens from challenging clinical samples using advanced NGS or multiplexed PCR approaches. The company has received European funding for COVID-related rapid testing solutions.[1][4] No therapeutic drugs in development.

Therapeutic areas: Infectious DiseasesOncology
Modalities: PCR-based diagnosticsNext-generation sequencing (NGS)-based diagnosticsqPCR-based mutation detection assayMultiplexing qPCR technology
Industry: Molecular Diagnostics

Partnerships

RAPID-COVID consortium partners include PrimaDiag (France), Biosistemika LLC (Slovenia), Agencia Sanitaria Costa del Sol/HCS Spain), Assistance Publique Hôpitaux de ParisFunding from Innovative Medicines Initiative/EU Horizon2020

Beyond the preview

Go deeper on GeneFirst.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GeneFirst.

Explore the full profile